Campbell; Jamie
Patent Applications and Registrations
Patent applications and USPTO patent grants for Campbell; Jamie.The latest application filed is for "binding molecules binding pd-l1 and lag-3".
- Campbell; Jamie - Cambridge GB
- CAMPBELL; Jamie - Babraham GB
| Patent | Date |
|---|---|
| Methods of treating comprising administering anti-OX40L antibodies Grant 11,396,550 - Campbell , et al. July 26, 2 | 2022-07-26 |
| Binding Molecules Binding Pd-l1 And Lag-3 App 20220185894 - Campbell; Jamie ; et al. | 2022-06-16 |
| Binding molecules binding PD-L1 and LAG-3 Grant 11,214,620 - Campbell , et al. January 4, 2 | 2022-01-04 |
| Antibodies, Uses & Methods App 20210395378 - CAMPBELL; Jamie ; et al. | 2021-12-23 |
| Anti-pd-l1 Antibodies App 20210380699 - CAMPBELL; Jamie ; et al. | 2021-12-09 |
| Antibodies, Uses & Methods App 20210087287 - CAMPBELL; Jamie ; et al. | 2021-03-25 |
| Anti-OX40L antibodies and methods of treating graft versus host disease Grant 10,669,342 - Campbell , et al. | 2020-06-02 |
| Methods of treating SLE with anti-OX40L antibodies Grant 10,654,935 - Campbell , et al. | 2020-05-19 |
| Antibodies and immunocytokines Grant 10,604,576 - Campbell , et al. | 2020-03-31 |
| Anti-pd-l1 And Il-2 Cytokines App 20190338032 - CAMPBELL; Jamie ; et al. | 2019-11-07 |
| Anti-pd-l1 Antibodies App 20190330351 - CAMPBELL; Jamie ; et al. | 2019-10-31 |
| Antibodies, Uses & Methods App 20190276547 - CAMPBELL; Jamie ; et al. | 2019-09-12 |
| Binding Molecules Binding Pd-l1 And Lag-3 App 20190256602 - Campbell; Jamie ; et al. | 2019-08-22 |
| Multispecific Antibodies For Immuno-oncology App 20190202917 - CAMPBELL; Jamie ; et al. | 2019-07-04 |
| Synergistic combinations of OX40L antibodies for the treatment of GvHD Grant 9,868,789 - Bland-Ward , et al. January 16, 2 | 2018-01-16 |
| Synergistic combinations of OX40L antibodies for the treatment of GvHD Grant 9,868,790 - Bland-Ward , et al. January 16, 2 | 2018-01-16 |
| Antibodies And Immunocytokines App 20170362321 - Campbell; Jamie ; et al. | 2017-12-21 |
| Antibodies, Uses & Methods App 20170327587 - Campbell; Jamie ; et al. | 2017-11-16 |
| Synergistic Combinations Of Ox40l Antibodies For The Treatment Of Gvhd App 20170327586 - Bland-Ward; Philip ; et al. | 2017-11-16 |
| Synergistic Combinations Of Ox40l Antibodies For The Treatment Of Gvhd App 20170260279 - Bland-Ward; Philip ; et al. | 2017-09-14 |
| Antibodies and immunocytokines Grant 9,617,338 - Campbell , et al. April 11, 2 | 2017-04-11 |
| Anti-hOX40L antibodies, uses, and methods Grant 9,587,030 - Campbell , et al. March 7, 2 | 2017-03-07 |
| Antibodies, Uses & Methods App 20170044250 - Campbell; Jamie ; et al. | 2017-02-16 |
| Antibodies and immunocytokines Grant 9,567,399 - Campbell , et al. February 14, 2 | 2017-02-14 |
| Synergistic Combinations Of Ox40l Antibodies For The Treatment Of Gvhd App 20170037137 - Bland-Ward; Philip ; et al. | 2017-02-09 |
| Antibodies, Uses & Methods App 20170002083 - Campbell; Jamie ; et al. | 2017-01-05 |
| Antibodies, Uses & Methods App 20160368997 - Campbell; Jamie ; et al. | 2016-12-22 |
| Synergistic combinations of OX40L antibodies for the treatment of GVHD Grant 9,512,229 - Bland-Ward , et al. December 6, 2 | 2016-12-06 |
| Synergistic Combinations Of Ox40l Antibodies For The Treatment Of Gvhd App 20160264675 - Bland-Ward; Philip ; et al. | 2016-09-15 |
| Anti-human OX40L antibodies and methods of treating graft versus host disease with the same Grant 9,434,785 - Bland-Ward , et al. September 6, 2 | 2016-09-06 |
| Anti-human OX40L antibodies Grant 9,234,043 - Campbell , et al. January 12, 2 | 2016-01-12 |
| Anti-human OX40L antibodies and methods of treatment Grant 9,139,653 - Campbell , et al. September 22, 2 | 2015-09-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 